Fundz

Epigenica raises $2.2M to drive shift in personalized medicine, led by Voima Ventures, to fuel growth and commercial expansion.

PRIVATEJun 30, 2025

Amount Raised

$2.2 Million

Round Type

Funding Round

StockholmBiotechnology

Investors

Navigare VenturesLeksell Social VenturesAlmi InvestVoima Ventures

Description

Stockholm-based Epigenica AB has closed a $2.2 million funding round to fuel its growth and commercial expansion across key markets. The round was led by Voima Ventures, with participation from Navigare Ventures, Leksell Social Ventures, and Almi Invest. Epigenica’s EpiFinder platform offers unique insights into epigenetics and its impact on treatment strategies. This funding validates the company's scientific and commercial progress.

Quick answer

Epigenica raised $2.2 Million in a Funding Round round, dated June 30, 2025. Investors: Navigare Ventures, Leksell Social Ventures, Almi Invest and Voima Ventures. Epigenica is based in Stockholm, Stockholm County, Sweden.

How much did Epigenica raise?
Epigenica raised $2.2 Million in a Funding Round round on June 30, 2025.
Who invested in Epigenica?
Navigare Ventures, Leksell Social Ventures, Almi Invest and Voima Ventures are named as investors in this round.
What does Epigenica do?
Epigenica is a life sciences technology company at the forefront of innovations in epigenetic research.
Where is Epigenica based and how big is it?
Epigenica is based in Stockholm, Stockholm County, Sweden.
Who are the decision-makers at Epigenica?
Fundz holds 1 contact at Epigenica. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Epigenica that raised within 45 days of this round, from Fundz verified event records.

  • MyndTec raised $100K on August 14, 2025.
  • Valthos raised $27M on August 14, 2025.
  • Ignitedata (Delaware) raised an undisclosed amount (Series A) on August 14, 2025.
  • Better Medicine raised $1.2M (Pre-Seed) on August 14, 2025.
  • Superluminal Medicines raised $5M on August 14, 2025.
  • X4 Pharmaceuticals raised $85M on August 13, 2025.

Who to call at Epigenica, and when

A new round usually means Epigenica is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Epigenica raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Epigenica, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Epigenica. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Epigenica

Location

Stockholm, Stockholm County, Sweden

About

Epigenica is a life sciences technology company at the forefront of innovations in epigenetic research. The company’s EpiFinder platform enables researchers to perform comprehensive epigenetic studies at unprecedented speed, scalability, and affordability. Epigenica is building a portfolio of products based on the EpiFinder platform to offer comprehensive high-throughput profiling at different depths of detail with an array of possible starting materials. The platform is powered by the company’s patented and proprietary high-throughput, multiplex, quantitative ChIP-seq technology (hmqChIP), the first commercial kit of its kind. With the advantages of the EpiFinder platform, Epigenica is helping researchers advance biomedical research, drug discovery and development, precision medicine, diagnostics, and therapeutics for aging and longevity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Epigenica raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Epigenica's next move

See what Strategic adds

Epigenica raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.